BCL2 and neoplasm: In a clinical study based on the use of silymarin, tumor growth inhibition, activation of DR5 receptor, and extrinsic apoptosis signaling pathway, a decrease in Bcl-2 levels followed by activation of caspases in succession was identified, which reinforced the pro-apoptotic characteristic of this natural compound.